Loading insider details...
Beta
Latest Form 4 (Jul 31, 2026): Grant/Award of 70,812 PCSA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 31, 2026 | Processa Pharmaceuticals, Inc. (PCSA) | Grant/Award | 70,812 | n/a |
| Mar 4, 2026 | Ventyx Biosciences, Inc. (VTYX) | Disposition to Issuer | 130,000 | n/a |
| Jun 13, 2025 | Janux Therapeutics, Inc. (JANX) | Grant/Award | 3,750 | n/a |
| Jun 6, 2025 | Ventyx Biosciences, Inc. (VTYX) | Grant/Award | 40,000 | n/a |
| Dec 27, 2024 | Ventyx Biosciences, Inc. (VTYX) | Purchase | 130,000 | $300.6K |
| Nov 7, 2024 | Janux Therapeutics, Inc. (JANX) | Other (see footnotes) | 4,611 | n/a |
| Jun 28, 2024 | Janux Therapeutics, Inc. (JANX) | Grant/Award | 2,500 | n/a |
| Jun 7, 2024 | Ventyx Biosciences, Inc. (VTYX) | Grant/Award | 33,000 | n/a |
| Mar 4, 2024 | Janux Therapeutics, Inc. (JANX) | Other (see footnotes) | 2,986 | n/a |
| Jan 23, 2024 | Ventyx Biosciences, Inc. (VTYX) | Grant/Award | 80,000 | n/a |